Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

BACKGROUND: Treatment of systemic onset juvenile idiopathic arthritis JIA (sJIA), although dramatically improved, remains a challenge. Experience from clinical practice will be presented using data from the German Biologics register (BiKeR) for evaluation of efficacy and safety of treatment with eta...

Descripción completa

Detalles Bibliográficos
Autores principales: Horneff, Gerd, Schulz, Anna Carina, Klotsche, Jens, Hospach, Anton, Minden, Kirsten, Foeldvari, Ivan, Trauzeddel, Ralf, Ganser, Gerd, Weller-Heinemann, Frank, Haas, Johannes Perter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700562/
https://www.ncbi.nlm.nih.gov/pubmed/29166924
http://dx.doi.org/10.1186/s13075-017-1462-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700562/
https://www.ncbi.nlm.nih.gov/pubmed/29166924
http://dx.doi.org/10.1186/s13075-017-1462-2

Ejemplares similares